Schedule 13G ownership disclosure

MBX Biosciences Inc

Common Stock, par value $0.0001 per share · CUSIP: 55287L101

Event date: 2025-09-30

Filing-level shares
1,995,759
Percent of class
4.3%
  • P. Kent Hawryluk

    Shares: 1,995,759 · Class: 4.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-25-282917
Form type
SCHEDULE 13G/A
Filer
Hawryluk P. Kent
CIK
CIK 1673991
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub